Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas

por Holdhoff, Matthias, Nicholas, M Kelly, Peterson, Richard A, Maraka, Stefania, Liu, Li C, Fischer, James H, Wefel, Jeffrey S, Fan, Timothy M, Vannorsdall, Tracy, Russell, Meredith, Iacoboni, Michaella, Tarasow, Theodore M, Hergenrother, Paul J, Dudek, Arkadiusz Z, Danciu, Oana C
Publicado 2023

Identification of metabolic pathways contributing to ER(+) breast cancer disparities using a machine-learning pipeline

por Santaliz-Casiano, Ashlie, Mehta, Dhruv, Danciu, Oana C., Patel, Hariyali, Banks, Landan, Zaidi, Ayesha, Buckley, Jermya, Rauscher, Garth H., Schulte, Lauren, Weller, Lauren Ro, Taiym, Deanna, Liko-Hazizi, Elona, Pulliam, Natalie, Friedewald, Sarah M., Khan, Seema, Kim, J. Julie, Gradishar, William, Hegerty, Scott, Frasor, Jonna, Hoskins, Kent F., Madak-Erdogan, Zeynep
Publicado 2023